Citigroup Lowers Amrize (NYSE:AMRZ) Price Target to $58.00

Key Points

• Citigroup lowered Amrize’s price target from $66 to $58 while maintaining a “buy” rating, implying about 21.85% upside from the stock’s $47.60 price.
• Analyst sentiment remains moderately positive, with a consensus target of $61.36; however, recent ratings include downgrades from Weiss Ratings and Truist Financial.
• Amrize reported quarterly EPS of $0.88, missing the $0.92 consensus estimate, on revenue of $3.50 billion. The stock has traded between $46.03 and $65.94 over the past year, while insiders purchased approximately $2.7 million of shares in the last 90 days.

Amrize (NYSE:AMRZ - Get Free Report) had its price target decreased by investment analysts at Citigroup from $66.00 to $58.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a "buy" rating on the stock. Citigroup's target price would suggest a potential upside of 21.85% from the company's current price.

AMRZ has been the topic of several other reports. Weiss Ratings downgraded Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, July 31st. Truist Financial reissued a "hold" rating and issued a $48.00 price objective (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Amrize in a report on Friday, June 26th. Stephens reissued an "overweight" rating and set a $65.00 price target on shares of Amrize in a research report on Monday, May 18th. Finally, Vertical Research upgraded Amrize from a "hold" rating to a "buy" rating and set a $70.00 price objective for the company in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $61.36.

Amrize Stock Performance

Shares of NYSE:AMRZ traded up $1.31 during midday trading on Tuesday, reaching $47.60. 3,491,854 shares of the company's stock traded hands, compared to its average volume of 3,206,509. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. Amrize has a one year low of $46.03 and a one year high of $65.94. The company has a market cap of $26.33 billion, a price-to-earnings ratio of 21.95, a P/E/G ratio of 0.98 and a beta of 0.12. The stock has a 50 day moving average of $51.79 and a 200 day moving average of $54.68.

Amrize (NYSE:AMRZ - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.17% and a net margin of 9.89%.The company had revenue of $3.50 billion during the quarter. As a group, equities research analysts anticipate that Amrize will post 2.76 EPS for the current fiscal year.

Insider Activity at Amrize

In related news, insider Nollaig Forrest acquired 2,000 shares of the firm's stock in a transaction on Friday, May 22nd. The stock was bought at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the completion of the purchase, the insider directly owned 20,139 shares of the company's stock, valued at approximately $1,011,984.75. The trade was a 11.03% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CTO Roald Brouwer acquired 1,500 shares of the company's stock in a transaction on Thursday, May 21st. The shares were purchased at an average cost of $49.84 per share, for a total transaction of $74,760.00. Following the acquisition, the chief technology officer owned 19,757 shares of the company's stock, valued at approximately $984,688.88. The trade was a 8.22% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 54,918 shares of company stock valued at $2,717,324 in the last ninety days. 0.54% of the stock is currently owned by insiders.

Institutional Trading of Amrize

A number of hedge funds have recently added to or reduced their stakes in AMRZ. Great Lakes Advisors LLC acquired a new position in shares of Amrize in the second quarter valued at approximately $16,975,000. HF Advisory Group LLC lifted its stake in shares of Amrize by 323.3% in the 2nd quarter. HF Advisory Group LLC now owns 21,325 shares of the company's stock worth $1,137,000 after acquiring an additional 16,287 shares during the period. Norman Fields Gottscho Capital Management LLC boosted its holdings in shares of Amrize by 4.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company's stock valued at $614,000 after acquiring an additional 475 shares in the last quarter. DMKC Advisory Services LLC increased its stake in shares of Amrize by 11.9% during the second quarter. DMKC Advisory Services LLC now owns 67,832 shares of the company's stock worth $3,615,000 after acquiring an additional 7,223 shares during the period. Finally, Grove Bank & Trust lifted its position in Amrize by 5.6% in the second quarter. Grove Bank & Trust now owns 17,124 shares of the company's stock valued at $913,000 after purchasing an additional 906 shares during the period.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source